[go: up one dir, main page]

CN1857278A - Externally applied compound gel and its preparing method - Google Patents

Externally applied compound gel and its preparing method Download PDF

Info

Publication number
CN1857278A
CN1857278A CN 200610024744 CN200610024744A CN1857278A CN 1857278 A CN1857278 A CN 1857278A CN 200610024744 CN200610024744 CN 200610024744 CN 200610024744 A CN200610024744 A CN 200610024744A CN 1857278 A CN1857278 A CN 1857278A
Authority
CN
China
Prior art keywords
carbomer
tinea
compound gel
add
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200610024744
Other languages
Chinese (zh)
Other versions
CN100443085C (en
Inventor
高静
高申
储藏
丁雪鹰
管斐
吕莹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CNB2006100247442A priority Critical patent/CN100443085C/en
Publication of CN1857278A publication Critical patent/CN1857278A/en
Application granted granted Critical
Publication of CN100443085C publication Critical patent/CN100443085C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明涉及一种复方外用凝胶及其制法,目的是提供一种以盐酸特比奈芬(Terbinafine Hydrochloride,TER-HCL)和丙酸氯倍他索(Clobetasol Propionate,CBT)为主要成分的,可治疗癣病(体癣 股癣 手足癣和头癣等)、念珠菌引起的皮肤酵母菌感染,以及由发霉菌引起的甲癣等疾病的外用凝胶及其制备方法。本发明使用方便、治愈率高,适合于皮肤病患者使用。The present invention relates to a compound external gel and its preparation method. The external gel and the preparation method thereof can be used for treating ringworm (tinea corporis, tinea cruris, tinea manus, tinea capitis, etc.), skin yeast infection caused by candida, and onychomycosis caused by fungus. The invention is convenient to use and has a high cure rate, and is suitable for skin disease patients.

Description

一种外用复方凝胶及其制备方法A kind of compound gel for external use and preparation method thereof

技术领域technical field

本发明涉及一种新型药物剂型,具体为一种治疗癣病(体癣、股癣、手足癣和头癣等)、念珠菌引起的皮肤酵母菌感染,以及由发霉菌引起的甲癣等疾病的外用复方凝胶及其制备方法。The invention relates to a new type of pharmaceutical dosage form, in particular to a treatment for ringworm (tinea corporis, jock itch, tinea manuum, tinea capitis, etc.), skin yeast infection caused by Candida, and onychomycosis caused by moldy fungus and other diseases Compound gel for external use and preparation method thereof.

背景技术Background technique

盐酸特比奈芬(Terbinafine Hydrochloride,TER-HCL)具有特异性抑制角鲨烯环氧化酶的作用,真菌细胞不断摄取角鲨烯,导致细胞膜破坏,致真菌细胞死亡,此为它的杀菌作用。另外,角鲨烯环氧化酶为麦角固醇形成的关键酶,由于角鲨烯不能环氧化致使敏感真菌细胞膜主要构成物即麦角固醇合成减少,从而抑制真菌细胞活性,此为它的抑菌作用。因此,盐酸特比奈芬的作用机制是选择性地抑制真菌合成和繁殖过程中所必需的氧化酶,从而达到杀菌和抑制真菌的双重作用,它还同时具有广谱抗真菌的作用。Terbinafine Hydrochloride (TER-HCL) has the effect of specifically inhibiting squalene cyclooxygenase. Fungal cells continuously ingest squalene, resulting in cell membrane damage and fungal cell death. This is its bactericidal effect. In addition, squalene epoxidase is the key enzyme for the formation of ergosterol. Since squalene cannot be epoxidized, the synthesis of ergosterol, the main component of the sensitive fungal cell membrane, is reduced, thereby inhibiting the activity of fungal cells. This is its Antibacterial effect. Therefore, the mechanism of action of terbinafine hydrochloride is to selectively inhibit the necessary oxidase in the process of fungal synthesis and reproduction, so as to achieve the dual effects of bactericidal and fungal inhibition, and it also has a broad-spectrum antifungal effect.

丙酸氯倍他索(Clobetasol Propionate,CBT)为肾上腺皮质激素类药物,具有较强的抗炎、抗瘙痒和血管收缩作用,临床用于治疗神经性皮炎、接触性皮炎、脂溢性皮炎等症。Clobetasol propionate (Clobetasol Propionate, CBT) is an adrenal cortex hormone drug, which has strong anti-inflammatory, anti-itching and vasoconstrictive effects, and is clinically used to treat neurodermatitis, contact dermatitis, seborrheic dermatitis, etc. disease.

本发明涉及的水性凝胶基质,具有易涂展,易洗除,无油腻感,能吸收组织渗出液而不妨碍皮肤正常功能的作用,同时,由于该基质的粘滞度较小,有利于药物的快速释放。The aqueous gel matrix involved in the present invention has the functions of being easy to spread, easy to wash and remove, no greasy feeling, and capable of absorbing tissue exudate without hindering the normal function of the skin. At the same time, due to the low viscosity of the matrix, it has Facilitate rapid drug release.

由盐酸特比奈芬和丙酸氯倍他索为主要成分制成外用复方凝胶,可起到高效杀菌的作用,且涂抹方便舒适无刺激性,适合于患有癣病、皮肤酵母菌感染,以及甲癣等疾病的患者使用。The compound gel for external use is made of terbinafine hydrochloride and clobetasol propionate as the main ingredients, which can effectively sterilize bacteria, and is convenient and comfortable to apply without irritation. It is suitable for people with ringworm and skin yeast infection. And patients with diseases such as onychomycosis.

但目前临床上尚缺少一种能治疗癣病(体癣、股癣、手足癣和头癣等)、念珠菌引起的皮肤酵母菌感染,以及由发霉菌引起的甲癣等疾病的外用复方凝胶。But there is still a lack of a kind of external compound condensate that can treat ringworm (tinea corporis, jock itch, tinea manuum and tinea capitis, etc.), skin yeast infection caused by Candida, and diseases such as onychomycosis caused by moldy fungi at present. glue.

发明内容Contents of the invention

本发明的目的是提供一种治疗癣病(体癣、股癣、手足癣和头癣等)、念珠菌引起的皮肤酵母菌感染,以及由发霉菌引起的甲癣等疾病的外用复方凝胶及其制备方法。The object of the present invention is to provide a kind of compound gel for external use for the treatment of ringworm (tinea corporis, jock itch, tinea manuum and tinea capitis, etc.), skin yeast infection caused by candida, and onychomycosis caused by moldy fungus and its preparation method.

本发明涉及一种外用复方凝胶剂,其特征在于处方主要成分为盐酸特比奈芬(0.01~20)%,丙酸氯倍他索(0.01~10)%,以及其他成分包括:卡波姆(0.1~5)%、羟丙甲基纤维素(0~20)%、pH调节剂(0.5~10)%、保湿剂(5~30)%、溶剂(10~80)%、防腐剂(0.01~1.5)%。The invention relates to a compound gel for external use, which is characterized in that the main ingredients of the prescription are terbinafine hydrochloride (0.01-20)%, clobetasol propionate (0.01-10)%, and other ingredients include: carbomer (0.1~5)%, hydroxypropyl methylcellulose (0~20)%, pH adjuster (0.5~10)%, humectant (5~30)%, solvent (10~80)%, preservative ( 0.01~1.5)%.

其中:所述pH调节剂包括但不仅限于磷酸氢二钠、磷酸二氢钠、三乙醇胺、乙二胺、月桂胺、碳酸氢钠、氢氧化钠等,可以单独或组合应用。Wherein: the pH regulator includes but not limited to disodium hydrogen phosphate, sodium dihydrogen phosphate, triethanolamine, ethylenediamine, laurylamine, sodium bicarbonate, sodium hydroxide, etc., which can be used alone or in combination.

所述保湿剂包括但不仅限于甘油、丙二醇、山梨醇、二甘醇、木糖醇等,可以单独或组合应用。The humectants include but are not limited to glycerin, propylene glycol, sorbitol, diethylene glycol, xylitol, etc., which can be used alone or in combination.

所述溶剂包括但不仅限于丙二醇、乙醇、纯化水、蒸馏水、注射用水等,可以单独或组合应用。The solvents include but are not limited to propylene glycol, ethanol, purified water, distilled water, water for injection, etc., and can be used alone or in combination.

所述防腐剂包括但不仅限于苯甲醇、尼泊金甲酯、尼泊金丙酯、尼泊金丁酯等,可以单独或组合应用。The preservatives include but are not limited to benzyl alcohol, methylparaben, propylparaben, butylparaben, etc., which can be used alone or in combination.

该剂型具体的制备方法如下所述:The specific preparation method of this dosage form is as follows:

第一步 取卡波姆,加保湿剂研磨润湿后,加适量水使卡波姆得以充分溶胀,得卡波姆基质;The first step is to take carbomer, add a moisturizer to grind and moisten it, then add an appropriate amount of water to fully swell the carbomer to obtain a carbomer matrix;

第二步 取羟丙甲基纤维素,加适量90℃水并快速搅拌,得均匀白色羟丙甲基纤维素溶液,将其加入卡波姆基质中混匀备用;The second step is to take hydroxypropyl methylcellulose, add an appropriate amount of water at 90°C and stir quickly to obtain a uniform white hydroxypropyl methylcellulose solution, add it to the carbomer matrix and mix well for later use;

第三步 取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入第二步所得基质中;The third step is to take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the matrix obtained in the second step while stirring;

第四步 向第三步所得混合物中滴加pH调节剂溶液和防腐剂,再以水加至全量,并搅拌均匀;The fourth step is to add the pH regulator solution and preservative to the mixture obtained in the third step, and then add water to the full amount, and stir evenly;

第五步 将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。The fifth step is to carry out primary filtration and fine filtration of the above liquid, and then fill it to obtain the compound gel for external use of the present invention.

本发明为水性凝胶剂,具有无油腻感,能吸收组织渗出液而不妨碍皮肤正常功能的作用,同时,由于该基质的粘滞度较小,有利于药物的快速释放。同时,该制剂给药后,易涂展和洗除,易于被患者接收,有助于提高患者的用药依从性,是一种有效的新型临床抗感染制剂。The invention is a water-based gel, which has no greasy feeling, can absorb tissue exudate without hindering the normal function of the skin, and at the same time, because the viscosity of the matrix is small, it is beneficial to the rapid release of drugs. At the same time, after the preparation is administered, it is easy to spread and wash off, and is easy to be accepted by patients, which helps to improve the medication compliance of patients, and is an effective new clinical anti-infection preparation.

具体实施方式Detailed ways

本发明所述外用复方凝胶剂包括主要成分盐酸特比奈芬和丙酸氯倍他索,以及卡波姆、羟丙甲基纤维素、pH调节剂、保湿剂、溶剂、防腐剂等,经过特定方法制备而得。为更好的说明本发明所述的外用复方凝胶剂的制备方法,特举例如下:The compound gel for external use of the present invention comprises main components terbinafine hydrochloride and clobetasol propionate, and carbomer, hypromellose, pH regulator, humectant, solvent, preservative, etc., after Prepared by a specific method. For a better description of the preparation method of the external compound gel of the present invention, special examples are as follows:

实施例1.外用复方凝胶剂的制备Embodiment 1. The preparation of compound gel for external use

处方:盐酸特比奈芬                       1.0gPrescription: Terbinafine Hydrochloride 1.0g

      丙酸氯倍他索                       0.03g                                                                                             

      卡波姆941                          0.5gCarbomer 941 0.5g

      羟丙甲基纤维素                     10.0g                                                                                                           

      三乙醇胺                           1.5g                                              

      甘油                               15.0gGlycerin 15.0g

      丙二醇                             10.0gPropylene Glycol 10.0g

      乙醇                               10.0mlEthanol 10.0ml

      苯甲醇                             0.5gBenzyl alcohol 0.5g

      纯化水                             加至100g                                                                                                                                                                     

制备方法:Preparation:

1.取卡波姆,加甘油研磨润湿后,加10ml纯化水使卡波姆得以充分溶胀,得卡波姆基质;1. Take carbomer, grind it with glycerin, add 10ml of purified water to fully swell the carbomer, and obtain the carbomer matrix;

2.取羟丙甲基纤维素,加15ml的90℃水并快速搅拌,得均匀白色羟丙甲基纤维素溶液,将其加入卡波姆基质中混匀备用;2. Take hydroxypropyl methylcellulose, add 15ml of 90°C water and stir quickly to obtain a uniform white hydroxypropyl methylcellulose solution, add it to the carbomer matrix and mix well for later use;

3.取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入卡波姆基质中;3. Take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the carbomer matrix under stirring;

4.取丙二醇缓缓加入上一步所得混合物中,并搅拌均匀;4. Slowly add propylene glycol to the mixture obtained in the previous step, and stir evenly;

5.向上一步所得混合物中滴加三乙醇胺、苯甲醇,再以纯化水加至全量,并搅拌均匀;5. Add triethanolamine and benzyl alcohol dropwise to the mixture obtained in the previous step, then add purified water to the full amount, and stir evenly;

6.将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。总量100g,共分装为10支,每支10g,盐酸特比奈芬含量0.1g/10g。6. The above-mentioned liquid is subjected to initial filtration and fine filtration, and then filled to obtain the compound gel for external use of the present invention. The total amount is 100g, divided into 10 sticks, each stick is 10g, and the content of terbinafine hydrochloride is 0.1g/10g.

实施例2.外用复方凝胶剂的制备Embodiment 2. The preparation of compound gel for external use

处方:盐酸特比奈芬                       1.0gPrescription: Terbinafine Hydrochloride 1.0g

      丙酸氯倍他索                       0.03g                                                                                             

      卡波姆941                          1.5gCarbomer 941 1.5g

      三乙醇胺                           2.5g                                            

      甘油                               10.0gGlycerin 10.0g

      二甘醇                             10.0gDiethylene glycol 10.0g

      乙醇                               10.0mlEthanol 10.0ml

      苯甲醇                             0.5gBenzyl alcohol 0.5g

      蒸馏水                             加至100gDistilled water Add up to 100g

制备方法:Preparation:

1.取卡波姆,加甘油研磨润湿后,加20ml蒸馏水使卡波姆得以充分溶胀,得卡波姆基质;1. Take carbomer, add glycerin to grind and moisten it, add 20ml of distilled water to fully swell the carbomer, and obtain the carbomer matrix;

2.取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入卡波姆基质中;2. Take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the carbomer matrix under stirring;

3.取二甘醇缓缓加入上一步所得混合物中,并搅拌均匀;3. Slowly add diethylene glycol to the mixture obtained in the previous step, and stir evenly;

4.向上一步所得混合物中滴加三乙醇胺、苯甲醇,再以蒸馏水加至全量,并搅拌均匀;4. Add triethanolamine and benzyl alcohol dropwise to the mixture obtained in the previous step, then add distilled water to the full amount, and stir evenly;

5.将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。总量100g,共分装为10支,每支10g,盐酸特比奈芬含量0.1g/10g。5. The above-mentioned liquid is subjected to primary filtration and fine filtration, and then filled to obtain the compound gel for external use of the present invention. The total amount is 100g, divided into 10 sticks, each stick is 10g, and the content of terbinafine hydrochloride is 0.1g/10g.

实施例3.外用复方凝胶剂的制备Embodiment 3. Preparation of compound gel for external use

处方:盐酸特比奈芬                       1.0gPrescription: Terbinafine Hydrochloride 1.0g

      丙酸氯倍他索                       0.05g                                                                                  

      卡波姆941                          1.5gCarbomer 941 1.5g

      碳酸氢钠                           2.5gSodium bicarbonate 2.5g

      二甘醇                             10.0gDiethylene glycol 10.0g

      山梨醇                             10.0gSorbitol 10.0g

      乙醇                               10.0mlEthanol 10.0ml

      尼泊金甲酯                         0.1gMethylparaben 0.1g

      纯化水                             加至100g                                                                                                                                                                     

制备方法:Preparation:

1.取卡波姆,加二甘醇研磨润湿后,加20ml纯化水使卡波姆得以充分溶胀,得卡波姆基质;1. Take carbomer, add diethylene glycol to grind and moisten it, add 20ml of purified water to fully swell the carbomer, and obtain the carbomer matrix;

2.取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入卡波姆基质中;2. Take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the carbomer matrix under stirring;

3.取丙二醇缓缓加入第二步所得混合物中,并搅拌均匀;3. Slowly add propylene glycol to the mixture obtained in the second step, and stir evenly;

4.向上一步所得混合物中滴加三乙醇胺、尼泊金甲酯,再以纯化水加至全量,并搅拌均匀;4. Add triethanolamine and methylparaben dropwise to the mixture obtained in the previous step, then add purified water to the full amount, and stir evenly;

5.将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。总量100g,共分装为10支,每支10g,盐酸特比奈芬含量0.1g/10g。5. The above-mentioned liquid is subjected to primary filtration and fine filtration, and then filled to obtain the compound gel for external use of the present invention. The total amount is 100g, divided into 10 sticks, each stick is 10g, and the content of terbinafine hydrochloride is 0.1g/10g.

实施例4.外用复方凝胶剂的制备Embodiment 4. Preparation of compound gel for external use

处方:盐酸特比奈芬                       1.0gPrescription: Terbinafine Hydrochloride 1.0g

      丙酸氯倍他索                       0.03g                                                                                             

      卡波姆941                          1.5gCarbomer 941 1.5g

      氢氧化钠                           2.5gSodium Hydroxide 2.5g

      甘油                               20.0gGlycerin 20.0g

      乙醇                               10.0mlEthanol 10.0ml

      尼泊金丙酯                         0.01g                                                           

      蒸馏水                             加至100gDistilled water Add up to 100g

制备方法:Preparation:

1.取卡波姆,加甘油研磨润湿后,加20ml蒸馏水使卡波姆得以充分溶胀,得卡波姆基质;1. Take carbomer, add glycerin to grind and moisten it, add 20ml of distilled water to fully swell the carbomer, and obtain the carbomer matrix;

2.取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入卡波姆基质中;2. Take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the carbomer matrix under stirring;

3.向上一步所得混合物中滴加氢氧化钠、尼泊金丙酯,再以蒸馏水加至全量,并搅拌均匀;3. Add sodium hydroxide and propylparaben dropwise to the mixture obtained in the previous step, then add distilled water to the full amount, and stir evenly;

4.将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。总量100g,共分装为10支,每支10g,盐酸特比奈芬含量0.1g/10g。4. The above-mentioned liquid is subjected to initial filtration and fine filtration, and then filled to obtain the compound gel for external use of the present invention. The total amount is 100g, divided into 10 sticks, each stick is 10g, and the content of terbinafine hydrochloride is 0.1g/10g.

Claims (4)

1. externally applied compound gel agent, its component comprises TER-HCL, clobetasol propionate, carbomer, pH regulator agent, wetting agent, solvent and antiseptic, the percentage by weight of each component is in it is characterized in that writing out a prescription:
TER-HCL 0.01~20%
Clobetasol propionate 0.01~10%
Carbomer 0.1~5%
Hydroxypropyl methylcellulose 0~20%
PH regulator agent 0.5~10%
Wetting agent 5~30%
Solvent 10~80%
Antiseptic 0.01~1.5%.
2. according to the described a kind of externally applied compound gel agent of claim 1, it is characterized in that:
Described pH regulator agent comprises sodium hydrogen phosphate, sodium dihydrogen phosphate, triethanolamine, ethylenediamine, lauryl amine, sodium bicarbonate, sodium hydroxide, can be separately or combination in any use;
Described wetting agent comprises glycerol, propylene glycol, sorbitol, diethylene glycol, xylitol, can be separately or combination in any use;
Described solvent comprises propylene glycol, ethanol, purified water, distilled water, water for injection, can be separately or combination in any use;
Described antiseptic comprises benzyl alcohol, methyl hydroxybenzoate, propylparaben, butoben, can be separately or combination in any use.
3. the preparation method of a kind of externally applied compound gel agent of stating according to claim 1 or 2 is characterized in that this method comprises by following steps to form:
The first step is got carbomer, after adding wetting agent and grinding moistening, add suitable quantity of water and make carbomer be able to abundant swelling, carbomer substrate;
Second step was got hydroxypropyl methylcellulose, add an amount of 90 ℃ of water and stir fast, evenly white hydroxypropyl methylcellulose solution, it is standby that it is added in carbomer substrate mixing;
The 3rd step was got TER-HCL and clobetasol propionate, behind dissolve with ethanol, under agitation slowly added in the second step gained substrate;
The 4th step dripped pH regulator agent solution and antiseptic in the 3rd step gained mixture, add to full dose with water again, and stir;
The 5th step was carried out just filter and fine straining with aforesaid liquid, carried out fill again and promptly got externally applied compound gel of the present invention.
4. comprise the tinea of tinea corporis, tinea cruris, tinea manus and pedis and tinea capitis according to the described a kind of externally applied compound gel agent of claim 1 in treatment, by the microbial skin yeast infection of beads, and by the application of mouldy microbial tinea unguium aspect.
CNB2006100247442A 2006-03-16 2006-03-16 A kind of compound gel for external use and preparation method thereof Expired - Fee Related CN100443085C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100247442A CN100443085C (en) 2006-03-16 2006-03-16 A kind of compound gel for external use and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100247442A CN100443085C (en) 2006-03-16 2006-03-16 A kind of compound gel for external use and preparation method thereof

Publications (2)

Publication Number Publication Date
CN1857278A true CN1857278A (en) 2006-11-08
CN100443085C CN100443085C (en) 2008-12-17

Family

ID=37296266

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100247442A Expired - Fee Related CN100443085C (en) 2006-03-16 2006-03-16 A kind of compound gel for external use and preparation method thereof

Country Status (1)

Country Link
CN (1) CN100443085C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107158273A (en) * 2017-06-08 2017-09-15 苏州凌科特新材料有限公司 Medical disinfection gel and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1524531A (en) * 2003-02-24 2004-09-01 北京亚科希药物研究所 Compound terbinafine hydrochloride composition of skin antibacterial drugs
CN1272012C (en) * 2003-06-23 2006-08-30 北京亚科希药物研究所 Dermatopathy therapeutic medicine compositions and its preparation method
AU2005258903A1 (en) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107158273A (en) * 2017-06-08 2017-09-15 苏州凌科特新材料有限公司 Medical disinfection gel and preparation method thereof

Also Published As

Publication number Publication date
CN100443085C (en) 2008-12-17

Similar Documents

Publication Publication Date Title
CN101032474A (en) Rasagiline transparent patch for curing and preventing neurological diseases and the preparing method thereof
CN1679472A (en) Antimycotic nail varnish composition
CN1324607A (en) Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt
CN1899291A (en) External use antifungal compound composition and its use
CN1679520A (en) A kind of compound analgesic cataplasm
CN101455654A (en) Arginine ibuprofen gel and preparation method thereof
CN1316965C (en) Transparent disappearing external administration carrier
CN1927181A (en) Terbinafine nano milk-like liquid antifungal medicine and its preparation
CN1857278A (en) Externally applied compound gel and its preparing method
CN1931165A (en) Nanometer antifungal econazole nitrate emulsion medicine and its prepn process
CN110693860B (en) Gel plaster containing ketoprofen and preparation method thereof
CN1151866A (en) Topical therapeutic composition for dermatitis
CN1943676A (en) Baiying gel and its preparation method and application
CN1543943A (en) Oral silymarin sustained-release preparation and preparation method thereof
CN1861059A (en) Hydrophilic gel type percutaneous plaster contg. capsaicin, and its prepn. method
CN1762349A (en) Externally applied ointment of ketorolac tromethamine and its preparation method
CN1480130A (en) Ointment for anti-inflammation, analgesia and rheumatism dispelling and preparation method thereof
CN1559410A (en) Itraconazole soft capsule and preparation method thereof
CN1957942A (en) External preparation of Levocetirizine hydrochloric acid
CN1457765A (en) Cetirizine hydrochloride gel
CN1634062A (en) Nalmefene Hydrochloride Nasal Administration Preparation
CN1460472A (en) Biquanide vanadium complex plaster preparation for curing diabetes and its application
CN1272012C (en) Dermatopathy therapeutic medicine compositions and its preparation method
CN1714787A (en) Tromethamine gel form medicinal composition
CN1634071A (en) A kind of gel for treating glaucoma and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081217

Termination date: 20130316